267 related articles for article (PubMed ID: 16601443)
1. Lethal midline granuloma-nasal natural killer/T-cell lymphoma.
Mendenhall WM; Olivier KR; Lynch JW; Mendenhall NP
Am J Clin Oncol; 2006 Apr; 29(2):202-6. PubMed ID: 16601443
[TBL] [Abstract][Full Text] [Related]
2. Treatment of lethal midline granuloma type nasal T-cell lymphoma.
Sakata K; Hareyama M; Ohuchi A; Sido M; Nagakura H; Morita K; Harabuchi Y; Kataura A
Acta Oncol; 1997; 36(3):307-11. PubMed ID: 9208902
[TBL] [Abstract][Full Text] [Related]
3. Treatment of localized non-Hodgkin's lymphomas of the head and neck: focusing on cases of non-lethal midline granuloma.
Sakata K; Hareyama M; Oouchi A; Sido M; Nagakura H; Morita K; Harabuchi Y; Kataura A; Hinoda Y
Radiat Oncol Investig; 1998; 6(4):161-9. PubMed ID: 9727875
[TBL] [Abstract][Full Text] [Related]
4. [Treatment option and outcome for patients with primary non-Hodgkin's lymphoma of the nasal cavity].
Yao B; Li YX; Song YW; Jin J; Liu YP; Wang WH; Wang SL; Sun YT; Yu ZH; Liu XF
Zhonghua Zhong Liu Za Zhi; 2006 Jan; 28(1):58-61. PubMed ID: 16737624
[TBL] [Abstract][Full Text] [Related]
5. Nasal NK/T-cell lymphoma causing diagnostic difficulties.
Nigidie A; Schneider J
Ethiop Med J; 2005 Jul; 43(3):197-201. PubMed ID: 16370552
[TBL] [Abstract][Full Text] [Related]
6. [Nasal T-cell lymphoma as a differential diagnosis of the midline granuloma syndrome].
Tigges G; Delank KW; Blasius S; Stoll W
Laryngorhinootologie; 1999 Mar; 78(3):139-43. PubMed ID: 10226981
[TBL] [Abstract][Full Text] [Related]
7. Lethal Epstein-Barr virus associated NK/T-cell lymphoma with primary manifestation in the conjunctiva.
Widmer S; Tinguely M; Egli F; Thiel MA
Klin Monbl Augenheilkd; 2005 Mar; 222(3):255-7. PubMed ID: 15785994
[TBL] [Abstract][Full Text] [Related]
8. Radiotherapy as primary treatment for stage IE and IIE nasal natural killer/T-cell lymphoma.
Li YX; Yao B; Jin J; Wang WH; Liu YP; Song YW; Wang SL; Liu XF; Zhou LQ; He XH; Lu N; Yu ZH
J Clin Oncol; 2006 Jan; 24(1):181-9. PubMed ID: 16382127
[TBL] [Abstract][Full Text] [Related]
9. Successful treatment of concurrent chemoradiotherapy for stage I nasal NK/T cell lymphoma: a report of two cases.
Niibe Y; Hayakawa K; Kitano M; Ishiyama H; Nakayama M; Yao K; Okamoto M
Anticancer Res; 2005; 25(6C):4403-6. PubMed ID: 16334116
[TBL] [Abstract][Full Text] [Related]
10. Extranodal nasal type NK/T-cell lymphoma: elucidating clinical prognostic factors for risk-based stratification of therapy.
Lee J; Park YH; Kim WS; Lee SS; Ryoo BY; Yang SH; Park KW; Kang JH; Park JO; Lee SH; Kim K; Jung CW; Park YS; Im YH; Kang WK; Lee MH; Ko YH; Ahn YC; Park K
Eur J Cancer; 2005 Jul; 41(10):1402-8. PubMed ID: 15963893
[TBL] [Abstract][Full Text] [Related]
11. Extranodal natural killer/T-cell lymphoma, nasal type: the significance of radiotherapeutic parameters.
Isobe K; Uno T; Tamaru J; Kawakami H; Ueno N; Wakita H; Okada J; Itami J; Ito H
Cancer; 2006 Feb; 106(3):609-15. PubMed ID: 16369986
[TBL] [Abstract][Full Text] [Related]
12. [Treatment outcome and prognosis of 112 patients with nasal and nasopharyngeal peripheral T cell lymphomas].
Zhang YJ; Ren ZM; Wu QL; He ZY; Huang Y; Xia YF; Lin TY; Cui NJ
Zhonghua Xue Ye Xue Za Zhi; 2006 Apr; 27(4):217-21. PubMed ID: 16875549
[TBL] [Abstract][Full Text] [Related]
13. Oral and maxillofacial pathology case of the month. Angiocentric T-Cell lymphoma (midline lethal granuloma).
Johnson CD; Busaidy KF; Bouquot JE
Tex Dent J; 2007 Aug; 124(8):764-5, 772-3. PubMed ID: 17867546
[No Abstract] [Full Text] [Related]
14. [Clinical features and prognosis of nasal type NK/T cell lymphoma].
Zhang YJ; Hu WH; Liu H; Cheng EC; Ren ZM; Xia YF; Cui NJ
Zhonghua Zhong Liu Za Zhi; 2006 Jan; 28(1):50-3. PubMed ID: 16737622
[TBL] [Abstract][Full Text] [Related]
15. [Prognostic factors of primary non-Hodgkin's lymphoma of the nasal cavity--a report of 129 cases].
Yao B; Li YX; Fang H; Jin J; Liu XF; Yu ZH
Ai Zheng; 2006 Apr; 25(4):465-70. PubMed ID: 16613682
[TBL] [Abstract][Full Text] [Related]
16. [Angiocentric T/NK cell lymphoma: a special clinical-pathological entity of lethal midline granuloma. A case report].
Koch M; Blatterspiel GJ; Niedobitek G; Constantinidis J
Laryngorhinootologie; 2001 Jul; 80(7):410-5. PubMed ID: 11488153
[TBL] [Abstract][Full Text] [Related]
17. Outcome of patients with nasal natural killer (NK)/T-cell lymphoma treated with radiotherapy, with or without chemotherapy.
Tham IW; Lee KM; Yap SP; Loong SL
Head Neck; 2006 Feb; 28(2):126-34. PubMed ID: 16240328
[TBL] [Abstract][Full Text] [Related]
18. A 38-year history of natural-killer-cell lymphoma.
Schrader C; Janssen D; Kneba M; Lennert K
N Engl J Med; 2004 Jan; 350(4):418-9. PubMed ID: 14736941
[No Abstract] [Full Text] [Related]
19. Clinical significance of cyclooxygenase-2 expression in extranodal natural killer (NK)/T-cell lymphoma, nasal type.
Shim SJ; Yang WI; Shin E; Koom WS; Kim YB; Cho JH; Suh CO; Kim JH; Kim GE
Int J Radiat Oncol Biol Phys; 2007 Jan; 67(1):31-8. PubMed ID: 17049184
[TBL] [Abstract][Full Text] [Related]
20. Treatment outcome of angiocentric T-cell and NK/T-cell lymphoma, nasal type: radiotherapy versus chemoradiotherapy.
Kim K; Chie EK; Kim CW; Kim IH; Park CI
Jpn J Clin Oncol; 2005 Jan; 35(1):1-5. PubMed ID: 15681596
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
